Broker Newswire
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
SUBSCRIBE
No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
No Result
View All Result
Broker Newswire
No Result
View All Result
Home Latest News General

Former IRS Employee Is Sentenced To Prison On Health Care Fraud Charge

by Jay Helton
November 27, 2017
1 min read
0
drugs and needles

Creative Commons

Share on FacebookShare on Twitter

Last week, it was announced that a former employee of the Internal Revenue Service had been sentenced to prison on a health care fraud charge related to misuse of government health insurance benefits. 69-year-old Ronald Lewis Hooper of Lynchburg was sentenced to 20 months in federal prison and three years of supervised release. The defendant has also been ordered to pay $549,607 in restitution. Hooper previously pleaded guilty to a single count of health care fraud.

Evidence presented during a previous hearing showed that Hooper misused his government health benefits to seek opiate drugs, including Phenergan, Nubian and others at emergency departments. The United States would have proven that the defendant had been seeking these drugs only after his primary physician began restricting the number of injections he provided to Hooper to two a week.

In return, Hooper sought more injections at hospital facilities throughout North Carolina, South Carolina, Georgia, Florida, Virginia, and West Virginia. Between December of 2002 and December of 2012, Hooper received services at hospitals and emergency rooms on at least 1,700 separate occasions. He sought injections of Nubian and Phenergan. His activities led to a loss of $824,000 in fraudulent medical payments. Additional details can be found here.

RELATED STORIES

Volkswagen must pay damages

Volkswagen must pay damages to buyers of manipulated diesel cars

May 25, 2020
Future Cloud Banking and Fintech

Future Cloud Predictions for Banking and Fintech Sector

April 23, 2020
Tags: fraudIRSlynchburgvirginia
Create your Web Presence with Namecheap

Recent Posts

  • Bitcoin and crypto spending is allowed by PayPal Now
  • The event in the live stream: Apple releases 5G-capable iPhone – Business
  • Volkswagen thriller: An unpopular supplier, audio recordings and a dead man
  • Tencent and WeChat also affected: Why Trump’s TikTok ban could harm Silicon Valley
  • Hacker attack on Twitter: “Group of young people” is supposed to be behind the attack on the social media platform

Category

  • Acquisitions
  • Broker Related
  • Earnings Reports
  • Economy
  • Enterprise
  • General
  • Internet
  • Investing
  • IPO News
  • Latest News
  • Layoffs
  • Markets
  • Online Trading
  • Opinion
  • OTC Markets
  • Penny Stocks
  • Personal Finance
  • Retirement
  • Saving money
  • Stocks
  • Technology

About Us

Broker Newswire (BN) is an exciting new online publication, which targets finances, brokers, mortgage and markets. BN, which is the nation’s leading provider of real estate, finance and market news and analysis.

  • About
  • Advertise
  • Privacy & Policy
  • Feedback

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Cryptocurrencies
    • Online Trading
    • Stocks
  • Markets
    • Earnings Reports
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Retirement
    • Saving money
  • Economy
  • Tech
    • Enterprise
    • Internet
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.